Filing Details

Accession Number:
0001181431-11-036290
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-13 16:06:27
Reporting Period:
2011-06-09
Filing Date:
2011-06-13
Accepted Time:
2011-06-13 16:06:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1135906 Zalicus Inc. ZLCS Pharmaceutical Preparations (2834) 043514457
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1350360 Jason Cole C/O Zalicus Inc.
245 First Street, 3Rd Floor
Cambridge MA 02142
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-09 70,948 $1.07 82,204 No 4 M Direct
Common Stock Disposition 2011-06-09 70,948 $2.33 11,256 No 4 S Direct
Common Stock Acquisiton 2011-06-09 54,687 $0.95 65,943 No 4 M Direct
Common Stock Disposition 2011-06-09 54,687 $2.33 11,256 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-06-09 47,620 $0.00 47,620 $1.07
Common Stock Stock Option (Right to Buy) Disposition 2011-06-09 18,416 $0.00 18,416 $1.07
Common Stock Stock Option (Right to Buy) Disposition 2011-06-09 4,837 $0.00 4,837 $1.07
Common Stock Stock Option (Right to Buy) Disposition 2011-06-09 75 $0.00 75 $1.07
Common Stock Stock Option (Right to Buy) Disposition 2011-06-09 54,687 $0.00 54,687 $0.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-12-21 2016-01-23 No 4 M Direct
8,371 2010-12-21 2017-01-17 No 4 M Direct
1,117 2010-12-21 2016-07-12 No 4 M Direct
7,738 2010-12-21 2017-07-11 No 4 M Direct
295,313 2011-01-15 2020-01-15 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on May 6, 2011.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.31 to $2.41. The reporting person undertakes to provide to Zalicus Inc., any security holder of Zalicus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
  3. The option vested with respect to 44,644 shares on December 21, 2010, and 2,976 shares on January 23, 2011.
  4. The option vested with respect to 18,416 shares on December 21, 2010, 1,674 shares on January 17, 2011 and 1,674 shares quarterly thereafter.
  5. The option vested with respect to 4,837 shares on December 21, 2010, 372 shares on January 12, 2011 and 372 shares quarterly thereafter.
  6. The option vested with respect to 4,395 shares on December 21, 2010, 488 shares on January 11, 2011 and 488 shares quarterly thereafter.
  7. The option vested with respect to 87,500 shares on January 15, 2011 and 21,875 shares quarterly thereafter.